|
ADPT Adaptive Biotechnologies Corp 1478320 |
| Balance Sheet |
|
Current Assets
|
$291,807,000.00 |
|
Assets
|
$505,943,000.00 |
|
Current Liabilities
|
$87,011,000.00 |
|
Liabilities
|
$281,702,000.00 |
|
Equity
|
$216,340,000.00 |
|
Shares Out
|
159697221.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-9,537,000.00 |
|
Investing Cash Flow
|
$9,143,000.00 |
| Market Analysis |
Market Cap
|
$3,861,478,803.78 |
|
Price
|
$22.93 |
|
BVPS
|
1.35 |
|
PB
|
17.91 |
|
EPS
|
-0.13 |
|
PS
|
12.60 |
|
FCF
|
$-10,333,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:21 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:17 |
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-05 |
-0.09 |
| Apr |
May |
Jun |
|
|
|
|
2026-05-05 |
-0.13 |
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-05 |
-0.17 |
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
0.06 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ADPT documents filed with the SEC.
ADPT Filings
Clear